Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation

Published:2014-12 Issue:12 Volume:45 Page:3637-3642
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

McGrath Emer R.¹,Kapral Moira K.¹,Fang Jiming¹,Eikelboom John W.¹,ó Conghaile Aengus¹,Canavan Michelle¹,O’Donnell Martin J.¹

Affiliation:

1. From the Massachusetts General Hospital, Boston (E.R.M.); National University of Ireland, Galway, Ireland (E.R.M.); University of Toronto, Toronto, Ontario, Canada (M.K.K.); Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada (M.K.K., J.F.); McMaster University, Hamilton, Ontario, Canada (J.W.E.); and National University of Ireland, Galway, Ireland (A.O.C., M.C., M.J.O.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference21 articles.

1. Antithrombotic Therapy for Atrial Fibrillation

2. Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

3. The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation

4. Canadian atrial fibrillation anticoaguiation (CAFA) study

5. Stroke Prevention in Atrial Fibrillation Study. Final results.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study;Europace;2024-01-30

2. Drug–drug interactions with warfarin: A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2021-05-16

3. COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA);Atherothrombosis;2020-01-15

4. Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?;Medicina;2019-09-13

5. Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis;Journal of Clinical Medicine;2019-09-13